Search

Sean E. Aeder

Examiner (ID: 2139, Phone: (571)272-8787 , Office: P/1642 )

Most Active Art Unit
1642
Art Unit(s)
1642
Total Applications
1939
Issued Applications
907
Pending Applications
201
Abandoned Applications
855

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 6442825 [patent_doc_number] => 20100144540 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-10 [patent_title] => 'CORRELATION OF MOLECULAR MARKERS WITH CLINICAL OUTCOME IN GBM PATIENTS RADIATION TREATED WITH OR WITHOUT GEFITINIB' [patent_app_type] => utility [patent_app_number] => 12/564698 [patent_app_country] => US [patent_app_date] => 2009-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 8101 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0144/20100144540.pdf [firstpage_image] =>[orig_patent_app_number] => 12564698 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/564698
Correlation of molecular markers with clinical outcome in GBM patients radiation treated with or without gefitinib Sep 21, 2009 Issued
Array ( [id] => 6187820 [patent_doc_number] => 20110171219 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-14 [patent_title] => 'TREATING CANCER STEM CELLS USING TARGETED CARGO PROTEINS' [patent_app_type] => utility [patent_app_number] => 13/119426 [patent_app_country] => US [patent_app_date] => 2009-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 25611 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20110171219.pdf [firstpage_image] =>[orig_patent_app_number] => 13119426 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/119426
TREATING CANCER STEM CELLS USING TARGETED CARGO PROTEINS Sep 20, 2009 Abandoned
Array ( [id] => 8920462 [patent_doc_number] => 08486393 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-07-16 [patent_title] => 'Monoclonal antibodies for CSPG4 for the diagnosis and treatment of basal breast carcinoma' [patent_app_type] => utility [patent_app_number] => 13/119428 [patent_app_country] => US [patent_app_date] => 2009-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 21 [patent_no_of_words] => 27560 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13119428 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/119428
Monoclonal antibodies for CSPG4 for the diagnosis and treatment of basal breast carcinoma Sep 17, 2009 Issued
Array ( [id] => 4433917 [patent_doc_number] => 07897741 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-03-01 [patent_title] => 'Cell cycle phase markers' [patent_app_type] => utility [patent_app_number] => 12/560519 [patent_app_country] => US [patent_app_date] => 2009-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 13 [patent_no_of_words] => 12936 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 87 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/897/07897741.pdf [firstpage_image] =>[orig_patent_app_number] => 12560519 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/560519
Cell cycle phase markers Sep 15, 2009 Issued
Array ( [id] => 6585180 [patent_doc_number] => 20100047847 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-25 [patent_title] => 'Methods for diagnosing ovarian cancer' [patent_app_type] => utility [patent_app_number] => 12/584832 [patent_app_country] => US [patent_app_date] => 2009-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 16412 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0047/20100047847.pdf [firstpage_image] =>[orig_patent_app_number] => 12584832 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/584832
Methods for diagnosing ovarian cancer Sep 10, 2009 Issued
Array ( [id] => 6371177 [patent_doc_number] => 20100075325 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-25 [patent_title] => 'COMPOSITIONS, KITS, AND METHODS FOR IDENTIFICATION, ASSESSMENT, PREVENTION, AND THERAPY OF BREAST CANCER' [patent_app_type] => utility [patent_app_number] => 12/557795 [patent_app_country] => US [patent_app_date] => 2009-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 44111 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0075/20100075325.pdf [firstpage_image] =>[orig_patent_app_number] => 12557795 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/557795
COMPOSITIONS, KITS, AND METHODS FOR IDENTIFICATION, ASSESSMENT, PREVENTION, AND THERAPY OF BREAST CANCER Sep 10, 2009 Abandoned
Array ( [id] => 6304440 [patent_doc_number] => 20100068736 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-18 [patent_title] => 'Novel Nucleotide and Amino Acid Sequences, and Assays and Methods of Use Thereof for Diagnosis of Lung Cancer' [patent_app_type] => utility [patent_app_number] => 12/557253 [patent_app_country] => US [patent_app_date] => 2009-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 123 [patent_figures_cnt] => 123 [patent_no_of_words] => 331211 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0068/20100068736.pdf [firstpage_image] =>[orig_patent_app_number] => 12557253 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/557253
Novel Nucleotide and Amino Acid Sequences, and Assays and Methods of Use Thereof for Diagnosis of Lung Cancer Sep 9, 2009 Abandoned
Array ( [id] => 6163513 [patent_doc_number] => 20110160293 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-30 [patent_title] => 'PRMT1 FOR TARGET GENES OF CANCER THERAPY AND DIAGNOSIS' [patent_app_type] => utility [patent_app_number] => 13/060672 [patent_app_country] => US [patent_app_date] => 2009-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 25646 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0160/20110160293.pdf [firstpage_image] =>[orig_patent_app_number] => 13060672 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/060672
PRMT1 for target genes of cancer therapy and diagnosis Aug 24, 2009 Issued
Array ( [id] => 6110306 [patent_doc_number] => 20110189186 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-04 [patent_title] => 'AFFECTING BONE RELATED CONDITIONS USING CD68 BLOCKING AGENTS' [patent_app_type] => utility [patent_app_number] => 13/061471 [patent_app_country] => US [patent_app_date] => 2009-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 8795 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0189/20110189186.pdf [firstpage_image] =>[orig_patent_app_number] => 13061471 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/061471
AFFECTING BONE RELATED CONDITIONS USING CD68 BLOCKING AGENTS Aug 16, 2009 Abandoned
Array ( [id] => 10082469 [patent_doc_number] => 09119800 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-09-01 [patent_title] => 'HIG2 and URLC10 epitope peptide and vaccines containing the same' [patent_app_type] => utility [patent_app_number] => 13/059618 [patent_app_country] => US [patent_app_date] => 2009-08-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 8 [patent_no_of_words] => 13277 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13059618 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/059618
HIG2 and URLC10 epitope peptide and vaccines containing the same Aug 13, 2009 Issued
Array ( [id] => 6062164 [patent_doc_number] => 20110200597 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-18 [patent_title] => 'SIGNAL PATHWAY ALTERATIONS AND DRUG TARGET ELEVATIONS IN PRIMARY METACHRONOUS METASTATIC COLORECTAL CANCER COMPARED TO NON-METASTATIC DISEASE' [patent_app_type] => utility [patent_app_number] => 13/057409 [patent_app_country] => US [patent_app_date] => 2009-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 7546 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0200/20110200597.pdf [firstpage_image] =>[orig_patent_app_number] => 13057409 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/057409
SIGNAL PATHWAY ALTERATIONS AND DRUG TARGET ELEVATIONS IN PRIMARY METACHRONOUS METASTATIC COLORECTAL CANCER COMPARED TO NON-METASTATIC DISEASE Aug 4, 2009 Abandoned
Array ( [id] => 6491617 [patent_doc_number] => 20100093556 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-15 [patent_title] => 'COMPOSITIONS AND METHODS FOR TREATING AND DIAGNOSING CANCER' [patent_app_type] => utility [patent_app_number] => 12/512655 [patent_app_country] => US [patent_app_date] => 2009-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 100809 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0093/20100093556.pdf [firstpage_image] =>[orig_patent_app_number] => 12512655 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/512655
Compositions and methods for treating and diagnosing cancer Jul 29, 2009 Issued
Array ( [id] => 7733202 [patent_doc_number] => 20120015835 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-19 [patent_title] => 'Devices and Methods for Enrichment and Alteration of Circulating Tumor Cells and Other Particles' [patent_app_type] => utility [patent_app_number] => 12/511028 [patent_app_country] => US [patent_app_date] => 2009-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 80 [patent_figures_cnt] => 80 [patent_no_of_words] => 28623 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0015/20120015835.pdf [firstpage_image] =>[orig_patent_app_number] => 12511028 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/511028
Devices and Methods for Enrichment and Alteration of Circulating Tumor Cells and Other Particles Jul 27, 2009 Abandoned
Array ( [id] => 6143134 [patent_doc_number] => 20110129849 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-02 [patent_title] => 'DETECTION OF PROSTATE CANCER USING PSA GLYCOSYLATION PATTERNS' [patent_app_type] => utility [patent_app_number] => 13/055868 [patent_app_country] => US [patent_app_date] => 2009-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 16587 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0129/20110129849.pdf [firstpage_image] =>[orig_patent_app_number] => 13055868 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/055868
DETECTION OF PROSTATE CANCER USING PSA GLYCOSYLATION PATTERNS Jul 26, 2009 Abandoned
Array ( [id] => 7504209 [patent_doc_number] => 20110265197 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-27 [patent_title] => 'Signatures and PCDeterminants Associated with Prostate Cancer and Methods of Use Thereof' [patent_app_type] => utility [patent_app_number] => 13/054468 [patent_app_country] => US [patent_app_date] => 2009-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 35034 [patent_no_of_claims] => 57 [patent_no_of_ind_claims] => 19 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0265/20110265197.pdf [firstpage_image] =>[orig_patent_app_number] => 13054468 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/054468
Signatures and PCDeterminants Associated with Prostate Cancer and Methods of Use Thereof Jul 15, 2009 Abandoned
Array ( [id] => 9285948 [patent_doc_number] => 08642274 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-02-04 [patent_title] => 'Immunotherapeutic method' [patent_app_type] => utility [patent_app_number] => 12/503512 [patent_app_country] => US [patent_app_date] => 2009-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 10 [patent_no_of_words] => 22585 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 252 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12503512 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/503512
Immunotherapeutic method Jul 14, 2009 Issued
Array ( [id] => 6102081 [patent_doc_number] => 20110165573 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-07 [patent_title] => 'METHOD TO DETECT PROSTATE CANCER IN A SAMPLE' [patent_app_type] => utility [patent_app_number] => 12/500749 [patent_app_country] => US [patent_app_date] => 2009-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 16704 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0165/20110165573.pdf [firstpage_image] =>[orig_patent_app_number] => 12500749 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/500749
Method to detect prostate cancer in a sample Jul 9, 2009 Issued
Array ( [id] => 7656774 [patent_doc_number] => 20110306043 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-15 [patent_title] => 'DEVICES AND METHODS FOR ENRICHMENT AND ALTERATION OF CIRCULATING TUMOR CELLS AND OTHER PARTICLES' [patent_app_type] => utility [patent_app_number] => 12/500541 [patent_app_country] => US [patent_app_date] => 2009-07-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 84 [patent_figures_cnt] => 84 [patent_no_of_words] => 44875 [patent_no_of_claims] => 67 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0306/20110306043.pdf [firstpage_image] =>[orig_patent_app_number] => 12500541 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/500541
DEVICES AND METHODS FOR ENRICHMENT AND ALTERATION OF CIRCULATING TUMOR CELLS AND OTHER PARTICLES Jul 8, 2009 Abandoned
Array ( [id] => 7534803 [patent_doc_number] => 08048425 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-11-01 [patent_title] => 'Cytotoxic ribonuclease variants' [patent_app_type] => utility [patent_app_number] => 12/497038 [patent_app_country] => US [patent_app_date] => 2009-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 13843 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/048/08048425.pdf [firstpage_image] =>[orig_patent_app_number] => 12497038 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/497038
Cytotoxic ribonuclease variants Jul 1, 2009 Issued
Array ( [id] => 6187747 [patent_doc_number] => 20110171191 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-14 [patent_title] => 'SUPPRESSION OF NEUROENDOCRINE DISEASES' [patent_app_type] => utility [patent_app_number] => 12/996643 [patent_app_country] => US [patent_app_date] => 2009-06-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 46986 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20110171191.pdf [firstpage_image] =>[orig_patent_app_number] => 12996643 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/996643
SUPPRESSION OF NEUROENDOCRINE DISEASES Jun 10, 2009 Abandoned
Menu